NFLAMMATION and/or infection lead to activation of
suggested that IL-1 may need to interact with the IL-6 it the hypothalamic-pituitary-adrenal (H-P-A) axis (1, 2).
induces endogenously in stimulating ACTH release. This For many years, this phenomenon was studied in models hypothesis was further supported by our finding that preemploying lipopolysaccharide (LPS), a component of bactetreatment with murine monoclonal anti-IL-6 antibody rial cell walls of gram-negative bacteria (3-6). More recently, blocked the IL-I -induced ACTH response (11). a number of proinflammatory cytokines, i.e. interleukin-1 LPS induces tne release of IL-I, 'TNF, and IL-6 (14), which (IL-1), IL-6, and tumor necrosis factor (TNF), were shown to may mediate its stimulatory effect on the H-P-A axis. Theresimilarly activate the H-P-A axis both in vivo and in vitro (7-fore, the use of cytokine blocking antibodies to modulate the 9). The finding that these biochemically distinct cytokines LPS-induced ACTH response should aid in elucidating the had similar effects suggested redundancy. Our previous mutual dependence and contribution of endogenously prowork, however, indicated that interaction of these cytokines duced individual cytokines. Indeed, Rivier et al. (5) reported was required for ACTH induction (10, 11).
that monoclonal anti-IL-I receptor antibody partially blocks More specifically, we demonstrated in C3H/HeN mice the H-P-A response to LPS in mice (5). In addition, depletion that within 2 h of ip administration, IL-1 is a potent inducer of cytokines, in particular IL-I, by destruction of macroof ACTH, whereas pharmacological amounts (up to 10 gg) phages using liposome-encapsulated dichloromethylene diof IL-6 induced only a negligible response (10). However, phosphonate blocks the H-P-A respon3e to subpyrogenic the combination of IL-1 and IL-6 produced a synergistic amounts of LPS in rats (6). response within 30 min of injection (10), and IL-1 induces Moreover, variations in the kinetics of appearance of IL-IL-6 within 2 h of injection (11-13). Together, these results 1, TNF, and IL-6 after LPS challenge have been observed (13, (15) (16) (17) (18) (19) (20) (21) , suggesting that these cytokines may play differReceived July 28, 1992. ent roles at different times. TNF levels were consistently Address all correspondence and requests for reprints to: Dr. Robert found to peak approximately 1 h after LPS administration S. Perlstein, USAF MC, EXH, AFRRI, Bethesda, Maryland 20889-5145 and then rapidly declined (13, (15) (16) (17) (18) (19) (20) , in part probably * This work was supported by the Armed Forces Radiobiology Research Institute, Defense Nuclear Agency, under work units 00129 and because TNF release is especially sensitive to negative feed-00105. The views presented in this paper are those of the authors; no back by the glucocorticoid end product of H-P-A activation endorsement by the Defense Nuclear Agency or the Department of (18, 19) . In contrast, IL-I and IL-6 levels were found to peak
Defense has been given or should be inferred. Research was conducted somewhat later (within 2-4 h) and were sustained longer atcording to the principles enunciated in the Guide for the Care and Use of Laboratory Animals prepared by the lnstitito ,-f Laboratory (15, [17] [18] [19] 21) . It was, therefore, postulated that TNF initiAnimal Resour-,, National lJ.scarch Council.
ates, while IL-I and IL-6 sustain, H-P-A activation after LPS exposure (8).
The AC Iit antibody used in this assay is derived from rabbits immuIn this report, we present results which indicate that IL-I, nized against ACTVI-(1-24), a region that is identical in human and for LPS-induced ACTH inducmurine ACTHs. The threshold sensitivity of this assav was 8 pgl/ml IL-6, and TNF are requiredfo P-nueACHidc tion, and their relative contributions depend on the time interval after LPS challenge.
Statistical anakysLs
In Figs. I and 3 , evaluation of the results was camed out using analysis of variance, followed by the Scheffe F test. In Figs 2 and 4, Materials and Methods comparison of the response to each cytokine treatment at each time point with the response to simultaneously injected vehicle was made Experimental animals using Student's t tet. Comparison of the response to combined cotokine treatment with the sum of the responses to each cytokine treatment Female C3H!HeN mice were purchased from the Animal Genetics given separately at each time point was made as a I degree of freedom and Production Branch, NCI (Frederick, MD). Mice were handled as contrast. For each time point, each P value stated reflects a Bonlerroni previously described (10).
correction for the number of tests run. In the first set of experiments, groups of four to six mice were injected ip with vehicle (0.5 ml pyrogen-free normal saline), control antibody, or antibodies directed against the IL-I receptor, IL-6, or TNF at 1630 h on day 1. At 0800 h the next morning (day 2), LPS was administered ip to Results all of the pretreated groups as well as a group that had not received any pretreatment. Either 2 or 4 h later, unanesthetized mice were decapitated LPS-induced ACTH release (model 130 Rodent Decapitator, Harvard Apparatus, South Natick, MA) with minimal stress to obtain plasma samples for ACTH.
The ACTH levels in the plasma of mice receiving various
In the second set of experiments, groups of four to six mice were amounts of LPS at 2, 4, and 6 h are presented in Table 1 . injected ip with vehicle, recombinant human IL-Ia (rhiL-la), rhlL-6, The administration of all doses of LPS resulted in a maximal recombinant human TNFa (rhTNFa), or combinations of these cytokines ACTH response at 2 h, which progressively diminished at 4 and decapitated 30-180 min later. In a final set of experiments, groups and 6 h. All maximal ACTH responses at 2 h were similar. of four to six mice were pretreated with vehicle and antibodies on day 1, as described in the preceding paragraph, injected with a combination Therefore, we chose 1 ug LPS to study the modulation of the of rhIL-la and rhTNFa at 0800 h on day 2, and decapitated 120 min 2 h ACTH response to LPS. The 4 h ACTH response was later.
similar after 5-50 gag LPS. Therefore, we chose 5 jig LPS to In addition, 5-10 noninjected control mice were killed on the day of study the modulation of the 4 h ACI H response to LPS. probably is related to genetic differences between these two (Nutley, NJ). rhIL-6 (SDZ 280-969, batch PPG 9001; SA, 5.2 X 10' U/ strains. mg) was a gift from Dr. E. Liehl, Sandoz, Vienna, Austria). rhTNFa (lot CP4026P08; SA, 9.6 X 106 U/mg) was provided by Biogen (Cambridge, MA). LPS (protein free; prepared from Escherichia coli K235 by the Effect of antibody pretreatment on the plasma level of A CTH 2 phenol-water extraction method) was kindly provided by Dr. Stefanie h after challenge with LPS Vogel, Uniformed Services University of the Health Sciences (Bethesda, MD). The recombinant cytokines were diluted in 0.5 ml pyrogen-free Figure IA demonstrates the effect of pretreatment with saline on the day of injection.
anti-lL-6 antibody, anti-ILLR antibody, anti-TNF antibody, the combination of anti-IL-IR antibody and anti-TNF antiAntibodies body, or antigalactosidase antib(idy on the 2 h ACTIH reRat monoclonal antibody to mouse rlL-6 (MP5 20F3) was prepared sponse to I Mg LPS. Pretreatment with anti-IL-6 antibody using semipurified Cos-7 mouse IL-6 as an immunogen, as previously completely blocked the response to LPS, while the combidescribed (22) . Rat monoclonal antibody to f0-galactosidase (GL 113) nation of anti-TNF antibody and anti-IL-IR antibody only was used as an isotype control. Rat monoclonal immunoglobulin GI, Measurement of ACTH in plasma received various amounts of LPS ip and then were decapitated to obtain plasma for ACTH measurements 2, 4, or 6 h later. Each value ACTH was assayed in plasma from decapitated mice using an "1I
shown is the mean ± SEM for 5 animals, except for the vehicle values, RIA kit (INCSTAR Corp,, Stillwater, MN), as previously described (10). which represent. 10 animals each. given separately, the responses to the combined injection were significantly greater than the sumn of the responses to each cytokine injected alone at 120 anti 180 min (Fig 2) , injection. Pretreatment with either of these antibodies pro- 40, rhTINFa and rhIL-6 t i l I We previously observed that suboptimal amounts of rhIL-- brain, whereas the anti-lL-6 antibody neut-alizes LPS-or ILOther mice were administered vehicle without antibody pretreatment.
CYTIOKINES AND) ACTHA RESPONSE TO' LI'S

Release of ACTH after the inject ion of a combination of
-I Blood samples were obtained 2 h after T+I or vehicle alone. Each bar 1-stimulated IL-6 produced in the hypothalamus and/or represents the mean ± SEM for 13-15 animals. a, P < 0. ---challenge w as not blocked by pretreatm ent w ith anti-IL-1R
120.
-or anti-TNF antibody given separately, but was diminished "" 110.
by the combination of these antibodies; moreover, pretreat-::
•m ent w ith either anti-IL-lR or anti-TN F antibody alone 10o totally blocked the 4 h ACTH response. Our previous obser-
90
.vations that IL-1 and IL-6 synergize in inducing ACTH t release (10) and that the 2 h ACTH response to lL-I may be -0.
-- Since anti-IL-6 antibody totally abrogated ACTH release, at each time point are also shown. Each time point represents the mean while the combination of anti-IL-I R and anti-TNF antibodies ± SEM of hormone determinations for 7-28 animals, a, P < 0.05 vs. the only partially blocked the ACTH response 2 h after LPS response to simultaneously injected vehicle; b, P < 0.05 vs. the responses to rhTNFa or rhIL-6 injected separately. administration, it is possible that in addition to IL-I and TNF, other factors cooperate with IL-b. Among these, the arachiWhen the early responses to the rhTNF/rhlL-6 combination donic acid cascade metabolites, i.e. prostaglandins, leukowere compared with those to I jug rhTNFa or 1.25 Mg rhILtrienes, and epoxygenase products, which have been shown 6 given separately, the responses to the combined injection to modulate CRH release from the hypothalamus (40) and were significantly greater than the responses to each cytokine ACTH release from the pituitary (41) in vitro, seem likely injected alone (but not significantly greater than the sum of candidates. Other possible factors are histamine (3) and IL-2 the responses to each cytokine injected alone; Fig. 4) .
.--------
(8, 9, 42). In addition to directly stimulating the hypothalamus and pituitary in conjunction with IL-6, LPIS-induced IL-1 and Discussion TNF also contribute to stimulation of the H-P-A axis by Previous studies demonstrate that IL-1, IL-6, and TNF inducing IL-6 production. In contrast to observations with each stimulate the II-1-t axis in vivo via a CRH-dependent anti-IL-6 antibody, pretreatment with either anti-IL-IR or mechanism (7-9, 26-32) and in vitro at the level of the anti-TNF antibody blocked the 4 h, but not the 2 h, ACTH hypothalamus and pituitary (7-9, 27, 33, 34). On a molar response to LPS. The greater efficacy of these antibodies at basis, IL-1 is a more potent stimulator than TNF or IL-6 (31, 4 h may be due in part to their ability to interfere with TNF/ IL-1 induction of IL-6. There is ample evidenCL that LPSaddition, may play an interactive role with IL-6 at both time induced elevation of IL-6 depends upon IL-A and TNF inpoints. The definitive explanation of how these cvtokines duced by LPS. LPS stimulates the release of IL-1 and TNF mediate the activation of the H-P-A axis by LPS will have in vitro (43, 44), including the production of IL-I in the to take into account the contribution of cytokines produced hypothalamus and pituitary (45, 46) and TNF in central in the hypothalamus and pituitary gland, and how and if nervous system microglial cells (47) . In vivo, serum levels of they are induced by circulating cytokines originating in the TNF peak before IL-I and IL-6 after LPS administration (13, periphery. 15-21). TNF and IL-I, in turn, both stimulate the release of IL-6 (11-13, 43, 44, 48-50 ). TNF is a much less potent inducer of !L-6 thep IL-L in mice (11). This may help to Acknowledgments explain why ip injection of TNF stimulated only a minimal
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